Babaahmadi M, et al. Rheumatoid arthritis: the old issue, the new therapeutic approach. Stem Cell Res Ther. 2023;14(1):268.

Article  PubMed  PubMed Central  Google Scholar 

Murayama MA, et al. Chemokines and chemokine receptors as promising targets in rheumatoid arthritis. Front Immunol. 2023;14:1100869.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Collaborators GRA. Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the global burden of Disease Study 2021. Lancet Rheumatol. 2023;5(10):e594–610.

Article  Google Scholar 

Wei M, Chu CQ. Prediction of treatment response: personalized medicine in the management of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2022;36(1):101741.

Article  PubMed  Google Scholar 

Tsaltskan V, Firestein GS. Targeting fibroblast-like synoviocytes in rheumatoid arthritis. Curr Opin Pharmacol. 2022;67:102304.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu Z, et al. Fibroblast-like synoviocytes in rheumatoid arthritis: surface markers and phenotypes. Int Immunopharmacol. 2021;93:107392.

Article  CAS  PubMed  Google Scholar 

Jang S, Kwon EJ, Lee JJ. Rheumatoid Arthritis: pathogenic roles of diverse immune cells. Int J Mol Sci. 2022;23(2):905.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng X, et al. Components of the sympathetic nervous system as targets to modulate inflammation - rheumatoid arthritis synovial fibroblasts as neuron-like cells? J Inflamm (Lond). 2023;20(1):9.

Article  CAS  PubMed  Google Scholar 

Wang J, et al. Single-cell communication patterns and their intracellular information flow in synovial fibroblastic osteoarthritis and rheumatoid arthritis. Immunol Lett. 2023;263:1–13.

Article  CAS  PubMed  Google Scholar 

Wang Z, et al. Tyro3 receptor tyrosine kinase contributes to pathogenic phenotypes of fibroblast-like synoviocytes in rheumatoid arthritis and disturbs immune cell balance in experimental arthritis. Clin Immunol. 2023;255:109753.

Article  CAS  PubMed  Google Scholar 

Makuch S, Więcek K, Woźniak M. The immunomodulatory and anti-inflammatory effect of curcumin on immune cell populations, cytokines, and in vivo models of rheumatoid arthritis. Pharmaceuticals (Basel). 2021;14(4):309.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Forneris F, et al. LSD1: oxidative chemistry for multifaceted functions in chromatin regulation. Trends Biochem Sci. 2008;33(4):181–9.

Article  CAS  PubMed  Google Scholar 

Wang Y, et al. LSD1 is required for euchromatic origin firing and replication timing. Signal Transduct Target Ther. 2022;7(1):102.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dong J, et al. A comprehensive comparative study on LSD1 in different cancers and tumor specific LSD1 inhibitors. Eur J Med Chem. 2022;240:114564.

Article  CAS  PubMed  Google Scholar 

Ma T, et al. KDM1A/LSD1 as a promising target in various diseases treatment by regulating autophagy network. Biomed Pharmacother. 2022;148:112762.

Article  CAS  PubMed  Google Scholar 

Gu F, et al. Biological roles of LSD1 beyond its demethylase activity. Cell Mol Life Sci. 2020;77(17):3341–50.

Article  CAS  PubMed  Google Scholar 

Kim D, et al. PKCα-LSD1-NF-κB-Signaling Cascade is crucial for Epigenetic Control of the inflammatory response. Mol Cell. 2018;69(3):398–e4116.

Article  CAS  PubMed  Google Scholar 

Liu W, et al. Knockdown of LSD1 ameliorates the severity of rheumatoid arthritis and decreases the function of CD4 T cells in mouse models. Int J Clin Exp Pathol. 2018;11(1):333–41.

PubMed  PubMed Central  Google Scholar 

Guo Y, et al. CD40L-Dependent pathway is active at various stages of Rheumatoid Arthritis Disease Progression. J Immunol. 2017;198(11):4490–501.

Article  CAS  PubMed  Google Scholar 

Walsh AM, et al. Triple DMARD treatment in early rheumatoid arthritis modulates synovial T cell activation and plasmablast/plasma cell differentiation pathways. PLoS One. 2017;12(9):e0183928.

Article  PubMed  PubMed Central  Google Scholar 

Brand DD, Latham KA, Rosloniec EF. Collagen-induced arthritis. Nat Protoc. 2007;2(5):1269–75.

Article  CAS  PubMed  Google Scholar 

Kondo N, Kuroda T, Kobayashi D. Cytokine networks in the pathogenesis of rheumatoid arthritis. Int J Mol Sci, 2021. 22(20).

McConkey B, et al. Effects of gold, dapsone, and prednisone on serum C-reactive protein and haptoglobin and the erythrocyte sedimentation rate in rheumatoid arthritis. Ann Rheum Dis. 1979;38(2):141–4.

Blaschke S, et al. Haptoglobin-α1, -α2, vitamin D-binding protein and apolipoprotein C-III as predictors of etanercept drug response in rheumatoid arthritis. Arthritis Res Ther. 2015;17(1):45.

Article  PubMed  PubMed Central  Google Scholar 

Osborn TM, et al. Decreased levels of the gelsolin plasma isoform in patients with rheumatoid arthritis. Arthritis Res Ther. 2008;10(5):R117.

Article  PubMed  PubMed Central  Google Scholar 

Nandi A, et al. The abundant phytocannabinoids in rheumatoid arthritis: therapeutic targets and molecular processes identified using Integrated Bioinformatics and Network Pharmacology. Life (Basel). 2023;13(3):700.

CAS  PubMed  PubMed Central  Google Scholar 

Hemmatzadeh M, et al. The role of immune regulatory molecules in rheumatoid arthritis: implication for etiopathogenesis and prospective for treatment. J Cell Physiol. 2022;237(9):3541–53.

Article  CAS  PubMed  Google Scholar 

Irwin MR, Straub RH, Smith MT. Heat of the night: sleep disturbance activates inflammatory mechanisms and induces pain in rheumatoid arthritis. Nat Rev Rheumatol. 2023;19(9):545–59.

Article  PubMed  Google Scholar 

Edilova MI, Akram A, Abdul-Sater AA. Innate immunity drives pathogenesis of rheumatoid arthritis. Biomed J. 2021;44(2):172–82.

Article  CAS  PubMed  Google Scholar 

Guo Q, et al. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018;6:15.

Article  PubMed  PubMed Central  Google Scholar 

Alivernini S, Firestein GS, McInnes IB. The pathogenesis of rheumatoid arthritis. Immunity. 2022;55(12):2255–70.

Article  CAS  PubMed  Google Scholar 

Sepriano A, et al. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis. 2023;82(1):107–18.

Article  CAS  PubMed  Google Scholar 

Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis: a review. JAMA. 2018;320(13):1360–72.

Article  PubMed  Google Scholar 

Ding Q, et al. Signaling pathways in rheumatoid arthritis: implications for targeted therapy. Signal Transduct Target Ther. 2023;8(1):68.

Article  PubMed  PubMed Central  Google Scholar 

Bergstra SA, et al. Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis. 2023;82(1):81–94.

Article  CAS  PubMed  Google Scholar 

Lortholary O, et al. Infectious complications of rheumatoid arthritis and psoriatic arthritis during targeted and biological therapies: a viewpoint in 2020. Ann Rheum Dis. 2020;79(12):1532–43.

Article  CAS  PubMed  Google Scholar 

Sparks JA, et al. Comparative effectiveness of treatments for rheumatoid arthritis in clinical practice: a systematic review. Semin Arthritis Rheum. 2023;62:152249.

Article  CAS  PubMed  Google Scholar 

Nygaard G, Firestein GS. Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nat Rev Rheumatol. 2020;16(6):316–33.

Article  PubMed  PubMed Central  Google Scholar 

Neumann E, et al. Rheumatoid arthritis progression mediated by activated synovial fibroblasts. Trends Mol Med. 2010;16(10):458–68.

Article  CAS  PubMed  Google Scholar 

Dimitroulas T, et al. Biologic therapies and systemic bone loss in rheumatoid arthritis. Autoimmun Rev. 2013;12(10):958–66.